Peptide Regulation Watch
FDA, compounding and peptide-status signals without sourcing guidance.
Get the weekly evidence briefing.
One concise briefing on longevity claims, source signals, evidence labels and regulatory watchpoints.
Direct answer
The weekly briefing is a source-aware editorial digest: claim checks, regulatory watchpoints and evidence updates. No protocols, medical advice, sourcing guidance or supplement marketing.
Choose a watchlist
Longevity Claim Checks
Weekly verdicts on high-intent claims people are asking about.
Gene Therapy Frontier Watch
Approved therapies, investigational work and reprogramming claims separated clearly.
Biological Age & Biomarker Briefing
Testing claims, clock caveats and metrics that should not be overread.
Rapamycin / Geroprotectors Watch
Drug-longevity claims, off-label context and human endpoint watchpoints.